Overview


According to FutureWise analysis the market for Peptide Synthesis is expected to reach US$ 1.06 billion by 2031 at a CAGR of 7.60%.

A peptide is made up of two or more amino acids connected by amide bonds that together create a chain of amino acids that is typically 2 to 70 amino acids long. Because they don't need to be folded for biological activity, peptides are different from proteins. Peptides are found naturally in both plants and animals as peptide hormones such as enkephalin, LHRH, and angiotensin, as well as toxins. Peptides have a lot of potential as both starting points for drug discovery and as standalone medications. They are also utilised extensively as antigens to produce antibodies and are found to have applications in vaccines, biomaterials, histology probes, and vaccines.

The pharmaceutical industry relies heavily on peptides as a source of finished drugs and a starting point for developing peptidomimetic or non-peptidic pharmaceuticals. Therapeutic peptides are known to be highly selective in binding to in vivo targets, making them frequently highly effective and very selective while posing relatively few risks. They are therefore anticipated to impact drug discovery in the future significantly. Today, the US Food & Drug Administration has approved the use of more than 60 peptide-based medications. Over 140 peptide pharmaceuticals are undergoing clinical trials, while more than 500 are undergoing preclinical testing.

FutureWise Market Research has published a report that provides an insightful analysis of peptide synthesis market trends that are affecting the overall market growth. This report will provide a detailed analysis of market share, regional insights, and competitor analysis that includes stature of key manufacturers operational in this industry.

According to the analysis conducted by FutureWise research analysts, the peptide synthesis market is estimated to register a considerable growth rate over the forecast period. This report lists the market segments and potential prospects available across this industry, in addition providing crucial information on the total valuation currently held by the industry. Moreover, this report will assist key management individuals in an organisation to enhance their decisions pertaining to business expansion as well as strategic changes for increasing customer base.

  • Genscript Biotech Corporation
  • Thermo Fisher Scientific
  • Merck KGAA
  • Bachem Holding Ag
  • Kaneka Corporation
  • Biotage AB
  • Syngene International Limited
  • Mesa Laboratories, Inc.
  • Cem Corporation
  • Proteogenix
  • Bio-synthesis Inc.
  • Dalton Pharma Services
  • Aapptec
  • Vivitide
  • Anygen Co., Ltd.
  • CSBIO
  • Advanced Chemtech
  • Luxembourg Bio Technologies Ltd.
  • JPT Peptide Technologies Gmbh
  • Ambiopharm Inc.

(Note: The list of the major players will be updated with the latest market scenario and trends)

Peptides are highly effective and specific pharmacological components. Due to the diversity of their biological effects, they are utilised in a wide range of therapeutic applications. Peptides are increasingly being thought of as potential active pharmaceutical ingredients because of their wide chemical space, high biological activity, high specificity, relative simplicity of synthesis, ready availability, and low toxicity. Peptides are also becoming more important in the management of renal failure, rare disorders, and cardiovascular and neurological diseases. Throughout the forecast period, the aforementioned factors are anticipated to propel market growth. Both tiny molecules and big molecules based on peptides fall within the category of biologics. Due to their location at the intersection of typical tiny molecules and massive proteins, peptides have generated a number of regulatory challenges. While sharing a similar synthesis process, the action mechanisms of many peptide medicines vary greatly. As a result, developing a consistent set of regulatory guidelines that can satisfactorily satisfy the safety and quality requirements for such a broad group of molecular entities with a variety of specific modes of action is a challenging task. The industry's expansion is anticipated to be hampered by the variable nature of peptide groups and a lack of therapeutic market regulation. Interest in personalised medicine has been generated by the concept of individualised therapy to ensure improved patient care. Personalised proteomics, or proteome profiling, which clarifies disease path mechanisms, is the next important advancement in personalised medicine. The technology will make it possible to automatically inject numerous chemicals needed for the ligand synthesis, allowing for the controlled and customised synthesis of peptides and enabling the use of proteomics for individualised treatment. Personalised medicine offers the ability to reduce costs while simultaneously improving healthcare quality. These developments in the field of personalised medicine will present growth prospects for players in the peptide synthesis industry.

By Products & Services

  • Reagents
  • Equipment
  • Services

By Reagents 

  • Resins
  • Amino acids
  • Coupling Reagents
  • Dyes and Fluorescent labelling reagents
  • Other Reagents

By Equipment 

  • Peptide Synthesizers
  • Chromatography Equipment
  • Lyophilizers

By Technology 

  • Solid-Phase Peptide Synthesis
  • Solution-Phase Peptide Synthesis
  • Hybrid & Recombinant Technology

By End User

  • Pharmaceutical & Biotechnology Companies
  • Contract Development & Manufacturing Organizations and Contract Research Organizations (CDMOs & CROs)
  • Academic & Research Institutes

By Region

  •  North America
  •  Europe
  • Asia Pacific 
  • Latin America
  •  Middle East & Africa

This market research report also emphasis on factors affecting the growth rate in various regions listed above. A deep-down analysis of region will also be provided in the final version of this market which is based on conclusion of primary interviews and secondary data point gathered during the process.

By region, the market is segmented into North America, Latin America, Europe, Asia-Pacific, and Middle East & Africa. North America registered highest share in the market in 2022. The dominance is caused by a variety of chronic conditions, such as diabetes, that require effective treatment in the United States, including an increase in sedentary desk jobs and a rising prevalence of obesity. For instance, the North America and Caribbean (NAC) region had a regional prevalence of 14.6% of persons aged 20 to 29 who had diabetes in 2021, according to the International Diabetic Federation's 2021 report. In this region, type 1 diabetes affects children and teenagers at the second-highest rate (193,000). The market in the analysed region is likely to be driven by increased demand for peptide therapies as a result of the high prevalence of diabetes. Also, the rising accessibility of advanced healthcare infrastructure and significant investments made by the major companies in this region to develop novel peptide synthesis technologies are projected to fuel the market's expansion. The US FDA's drive for expedited drug approval is also anticipated to fuel market expansion in this region throughout the course of the forecast period, helping it to maintain its dominant position in the peptide synthesis market.


  • Tier 1 players- established companies in the market with a major market share
  • Tier 2 players
  • Emerging players which are growing rapidly
  • New Entrants

  • Growth prospects
  • SWOT analysis
  • Key trends
  • Key data-points affecting market growth

  • To provide with an exhaustive analysis on the Peptide Synthesis Market By Products & Services, By Reagents, By Equipment, By Technology, By End User and By Region.
  • To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
  • To evaluate and forecast micro-markets and the overall market
  • To predict the market size, in key regions— North America, Europe, Asia Pacific, Latin America and Middle East and Africa.
  • To record and evaluate competitive landscape mapping- product launches, technological advancements, mergers and expansions

  • We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
  • The customization Mobility Care offered are free of charge with purchase of any license of the report
  • You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com.

Table of Contents


  • 1.   Market Introduction
    •   1. Objectives of the Study
        2. Market Definition
        3. Market Scope
         3.1. Years Considered for the Study
         3.2. Market Covered
        4. Currency
        5. Limitations
        6. Stakeholders
  • 2.   Research Methodology
    •   1. Research Data
         1.1. Secondary Data
          1.1.1. Key Data from Secondary Sources
         1.2. Primary Data
          1.2.1. Key Data from Primary Sources
        2. Market Size Estimation
        3. Market Breakdown and Data Triangulation
        4. Assumptions for the Study
  • 3.   Executive Summary
    •   1. Market Outlook
        2. Segment Outlook
        3. Competitive Insights
  • 4.   Peptide Synthesis Market Variables, Trends and Scope
    •      1. Market Lineage Outlook
        2. Penetration and Growth Prospect Mapping
        3. Industry Value Chain Analysis
        4. Cost Analysis Breakdown
        5. Technology Overview
        6. Regulatory Framework
         6.1. Reimbursement Framework
         6.2. Standards and Compliances

  • 5.   Market Overview
    •   1. Market Dynamics
         1.1. Market Driver Analysis
          1.1.1. Increasing focus of Peptide Synthesis Market Companies on Brand Protection
          1.1.2. Untapped Opportunities in Emerging Regions
         1.2. Market Restraint Analysis
          1.2.1. High Cost Associated with Implementation of Predictive Analysis
         1.3. Industry Challenges
          1.3.1. Presence of Ambiguous Regulatory Framework
  • 6.   Peptide Synthesis Market Analysis Tools
    •   1. Industry Analysis - Porter’s
         1.1. Supplier Power
         1.2. Buyer Power
         1.3. Substitution Threat
         1.4. Threat from New Entrants
         1.5. Competitive Rivalry
        2. Pestel Analysis
         2.1. Political Landscape
         2.2. Environmental Landscape
         2.3. Social Landscape
         2.4. Technology Landscape
         2.5. Legal Landscape
        3. Major Deals And Strategic Alliances Analysis
         3.1. Joint Ventures
         3.2. Mergers and Acquisitions
         3.3. Licensing and Partnership
         3.4. Technology Collaborations
         3.5. Strategic Divestments
        4. Market Entry Strategies
        5. Case Studies
  • 7.   Peptide Synthesis Market, By Products & Services Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Reagents
        2. Equipment
        3. Services

  • 8.   Peptide Synthesis Market, By Reagents Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Resins
        2. Amino acids
        3. Coupling Reagents
        4. Dyes and Fluorescent labeling reagents
        5. Other Reagents

  • 9.   Peptide Synthesis Market, By Equipment Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Peptide Synthesizers
        2. Chromatography Equipment
        3. Lyophilizers

  • 10.   Peptide Synthesis Market, By Technology Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Solid-Phase Peptide Synthesis
        2. Solution-Phase Peptide Synthesis
        3. Hybrid and Recombinant Technology

  • 11.   Peptide Synthesis Market, By End User Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Pharmaceutical and Biotechnology Companies
        2. Contract Development and Manufacturing Organizations And Contract Research Organizations (CDMOs and CROs)
        3. Academic and Research Institutes

  • 12.   North America Peptide Synthesis Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. U.S.A
         2.2. Canada
         2.3. Mexico
        3. Market Size (USD Million) Forecast for North America 2023-2031

  • 13.   Latin America Peptide Synthesis Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Brazil
         2.2. Venezuela
         2.3. Argentina
         2.4. Rest of Latin America
        3. Market Size (USD Million) Forecast for Latin America 2023-2031

  • 14.   Europe Peptide Synthesis Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Germany
         2.2. U.K
         2.3. France
         2.4. Italy
         2.5. Spain
         2.6. Russia
         2.7. Poland
         2.8. Rest of Europe
        3. Market Size (USD Million) Forecast for Europe 2023-2031

  • 15.   Asia Pacific Peptide Synthesis Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Japan
         2.2. China
         2.3. India
         2.4. Australia and New Zealand
         2.5. ASEAN
         2.6. Rest of Asia Pacific
        3. Market Size (USD Million) Forecast for Asia Pacific 2023-2031

  • 16.   Middle East and Africa Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. GCC
         2.2. Israel
         2.3. South Africa
         2.4. Rest of MEA
        3. Market Size (USD Million) Forecast for MEA 2023-2031

  • 17.   Market Share Analysis and Competitive Landscape
    •   1. Global Landscape - Key Players, Revenue and Presence
        2. Global Share Analysis - Key Players (Tier 1, Tier 2, Tier 3)
        3. Global Emerging Companies
        4. North America - Market Share Analysis and Key Regional Players
        5. Europe - Market Share Analysis and Key Regional Players
        6. Asia Pacific - Market Share Analysis and Key Regional Players
        7. Global Key Player - Growth Matrix
  • 18.   Company Profiles (Competition Dashboard, Competitors Deep Dive, Products Offered and Financial Layouts)
    •   1. Genscript Biotech Corporation
         1.1. Company Overview
         1.2. Product Portfolio
         1.3. SWOT Analysis
         1.4. Financial Overview
         1.5. Strategic Overview
        2. Thermo Fisher Scientific
         2.1. Company Overview
         2.2. Product Portfolio
         2.3. SWOT Analysis
         2.4. Financial Overview
         2.5. Strategic Overview
        3. Merck KGAA
         3.1. Company Overview
         3.2. Product Portfolio
         3.3. SWOT Analysis
         3.4. Financial Overview
         3.5. Strategic Overview
        4. Bachem Holding Ag
         4.1. Company Overview
         4.2. Product Portfolio
         4.3. SWOT Analysis
         4.4. Financial Overview
         4.5. Strategic Overview
        5. Kaneka Corporation
         5.1. Company Overview
         5.2. Product Portfolio
         5.3. SWOT Analysis
         5.4. Financial Overview
         5.5. Strategic Overview
        6. Biotage AB
         6.1. Company Overview
         6.2. Product Portfolio
         6.3. SWOT Analysis
         6.4. Financial Overview
         6.5. Strategic Overview
        7. Syngene International Limited
         7.1. Company Overview
         7.2. Product Portfolio
         7.3. SWOT Analysis
         7.4. Financial Overview
         7.5. Strategic Overview
        8. Mesa Laboratories, Inc.
         8.1. Company Overview
         8.2. Product Portfolio
         8.3. SWOT Analysis
         8.4. Financial Overview
         8.5. Strategic Overview
        9. Cem Corporation
         9.1. Company Overview
         9.2. Product Portfolio
         9.3. SWOT Analysis
         9.4. Financial Overview
         9.5. Strategic Overview
        10. Proteogenix
         10.1. Company Overview
         10.2. Product Portfolio
         10.3. SWOT Analysis
         10.4. Financial Overview
         10.5. Strategic Overview
        11. Bio-synthesis Inc.
         11.1. Company Overview
         11.2. Product Portfolio
         11.3. SWOT Analysis
         11.4. Financial Overview
         11.5. Strategic Overview
        12. Dalton Pharma Services
         12.1. Company Overview
         12.2. Product Portfolio
         12.3. SWOT Analysis
         12.4. Financial Overview
         12.5. Strategic Overview
        13. Aapptec
         13.1. Company Overview
         13.2. Product Portfolio
         13.3. SWOT Analysis
         13.4. Financial Overview
         13.5. Strategic Overview
        14. Vivitide
         14.1. Company Overview
         14.2. Product Portfolio
         14.3. SWOT Analysis
         14.4. Financial Overview
         14.5. Strategic Overview
        15. Anygen Co., Ltd.
         15.1. Company Overview
         15.2. Product Portfolio
         15.3. SWOT Analysis
         15.4. Financial Overview
         15.5. Strategic Overview
        16. CSBIO
         16.1. Company Overview
         16.2. Product Portfolio
         16.3. SWOT Analysis
         16.4. Financial Overview
         16.5. Strategic Overview
        17. Advanced Chemtech
         17.1. Company Overview
         17.2. Product Portfolio
         17.3. SWOT Analysis
         17.4. Financial Overview
         17.5. Strategic Overview
        18. Luxembourg Bio Technologies Ltd.
         1. Company Overview
         2. Product Portfolio
         3. SWOT Analysis
         4. Financial Overview
         5. Strategic Overview
        19. JPT Peptide Technologies Gmbh
         19.1. Company Overview
         19.2. Product Portfolio
         19.3. SWOT Analysis
         19.4. Financial Overview
         19.5. Strategic Overview
        20. Ambiopharm Inc.
         20.1. Company Overview
         20.2. Product Portfolio
         20.3. SWOT Analysis
         20.4. Financial Overview
         20.5. Strategic Overview

  • 19.   Pre and Post COVID-19 Impact
    •   1. Positive influence on the healthcare industry
        2. The financial disruption of the manufacturing sector
        3. Impact of COVID-19 on emerging companies
        4. Significant mandates in the healthcare regulations initiated by administrations
        5. The overall economic slowdown of the developing and developed nations
  • 20.   FutureWise SME Key Takeaway Points for Client
Partner

Our Clients